References:
- Donnino MW, Salciccioli JD, Howell MD, et al. BMJ. 2014;348:g3028.
- Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Lancet. 2018;391(10116):125-132.
- Ferrer R, Martin-Loeches I, Phillips G, et al. Crit Care Med. 2014;42(8):1749-1755.
- Fonarow GC, Smith EE, Saver JL, et al. Circulation. 2011;123(7):750-758.
- Davidoff J, Fowler R, Gordon D, et al. JEMS. 2005;30(10):s20-s23. Research sponsored by
Teleflex
Incorporated.
- Leidel BA, Kirchhoff C, Bogner V, et al. Resuscitation. 2012;83(1):40-45.
- Dolister M, Miller S, Borron S, et al. J Vasc Access. 2013;14(3):216-224. Research
sponsored by
Teleflex
Incorporated.
- Lee PJ, Lee C, Rattner P, et al. Crit Care Med. 2015;43(6):1233-1238.
- Ross EM, Mapp J, Kharod C, et al. Am J Disaster Med. Spring 2016;11(s):119-123.
- Costantino TG, Kirtz JF, Satz WA. J Emerg Med. 2010;39(4):462-467.
doi:10.1016/j.jemermed.2009.02.004.
*Epinephrine administered in hospital cardiac arrest.
**The Arrow™ EZ-IO™ System is indicated for intraosseous access
anytime
in which vascular access is
difficult to obtain
in emergent, urgent or medically
necessary cases for up to 24 hours. For patients ≥ 12 years old, the device may be extended for up to
48 hours when
alternate intravenous access is not
available or reliably established.
† Analysis limited to administration of tranexamic acid.Data captured until 3 hours had elapsed.
‡Door-to-needle time for tPA.
§Placement mean time is measured from package opening to confirmation of blood/marrow aspirate.
||All complications, including non-serious. Insertion sites were inspected 24 hours after initial
placement.
¥ The measured time of each procedure began with arrival at patient’s side and concluded with
fluid/medication delivery.
#Time measured is patient arrival to the first dose of epinephrine.
Rx Only.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
The Arrow™ EZ-IO™ Needle Set is Sterile, Single Use: Do not reuse,
reprocess or re-sterilize. Reuse of
device creates a
potential risk of serious injury and/or
infection which may lead to death. Refer to Instructions for Use for complete warnings, indications,
contraindications,
precautions, and potential
complications.
Teleflex, the Teleflex logo, Arrow, and EZ-IO are trademarks or registered
trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other
countries. All other trademarks or registered trademarks are the property of their respective owners.
MC-008765Rev0.1
